Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$1.19 USD
-0.02 (-1.65%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.20 +0.01 (0.84%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth NA Momentum NA VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TRIB 1.19 -0.02(-1.65%)
Will TRIB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TRIB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TRIB
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial
TRIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Trinity Biotech's Stock Rises After Acquisition of Metabolomics
Other News for TRIB
TRIB forms MACD Bullish Signal Line Cross on September 18
Is TRIB primed for volatility? Narrow Range Bar shows up after sinking 1.67%
Is TRIB getting ready to pop? Narrow Range Bar shows up after gaining 0.84%
TRIB forms NR7 on September 15
TRIB forms 1,2,3 Retracement Bearish on September 12